Human-like immune responses in CD46 transgenic mice

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 433-440

  Johansson, Linda ^b   Rytkönen, Anne ^a   Wan, Hong ^d   Bergman, Peter ^c   Plant, Laura ^d   Agerberth, Birgitta ^c   Hökfelt, Tomas ^c   Jonsson, Ann Beth ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; CYCLOOXYGENASE 2; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MEMBRANE COFACTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INDUCTION; IMMUNE RESPONSE; LEUKOCYTE COUNT; MACROPHAGE; MENINGOCOCCOSIS; MICROGLIA; NEISSERIA MENINGITIDIS; NEUTROPHIL; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 21244472607     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.433     Document Type: Article

References (56)

1. van Deuren, M., P. Brandtzaeg, and J. W. van der Meer. 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13: 144-166.
2. Källström, H., M. K. Liszewski, J. P. Atkinson, and A-B. Jonsson. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25: 639-647.
3. Liszewski, M. K., T. W. Post, and J. P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9: 431-455.
4. Liszewski, M. K., T. C. Farries, D. M. Lublin, I. A. Rooney, and J. P. Atkinson. 1996. Control of the complement system. Adv. Immunol. 61: 201-283.
5. Sagerman, A., J. P. Atkinson, M. Marttila, V. Dennerquist, G. Wadell, and N. Arnberg. 2003. Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77: 9183-9191.
6. Wu, E., S. A. Trauger, L. Pache, T. M. Mullen, D. J. von Seggern, G. Siuzdak, and G. R. Nemerow. 2004. Membrane cofactor protein is a receptor for adenovirus associated with epidemic keratoconjunctivitis. J. Virol. 78: 3897-3905.
7. Manchester, M., M. K. Liszewski, J. P. Atkinson, and M. B. Oldstone. 1994. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc. Natl. Acad. Sci. USA 91: 2161-2165.
8. Dörig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 22: 295-305.
9. Okada, N., M. K. Liszewski, J. P. Atkinson, and M. Caparon. 1995. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc. Natl. Acad. Sci. USA 92: 2489-2493.
10. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67: 6025-6032.
11. Santoro, F., P. E. Kennedy, G. Locatelli, M. S. Malnati, E. A. Berger, and P. Lusso. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell 99: 817-827.
12. Emonts, M., J. A. Hazelzet, R. de Groot, and P. W. Hermans. 2003. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect. Dis. 3: 565-577.
13. DeLeo, F. R. 2004. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 9: 399-413.
14. Seely, A. J., J. L. Pascual, and N. V. Christou. 2003. Science review: cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance. Crit. Care 7: 291-307.
15. Polfliet, M. M., P. J. Zwijnenburg, A. M. van Furth, T. van der Poll, E. A. Dopp, C. Renardel de Lavalette, E. M. van Kesteren-Hendrikx, N. van Rooijen, C. D. Dijkstra, and T. K. van den Berg. 2001. Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J. Immunol. 167: 4644-4650.
16. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
17. Brandtzaeg, P., T. E. Mollnes, and P. Kierulf. 1989. Complement activation and endotoxin levels in systemic meningococcal disease. J. Infect. Dis. 160: 58-65.
18. Brandtzaeg, P., R. Ovstebo, and P. Kierulf. 1992. Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J. Infect. Dis. 166: 650-652.
19. Brandtzaeg, P., R. Ovstebo, and P. Kierulf. 1995. Bacteremia and compartmentalization of LPS in meningococcal disease. Prog. Clin. Biol. Res. 392: 219-233.
20. Pugin, J., R. J. Ulevitch, and P. S. Tobias. 1993. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J. Exp. Med. 178: 2193-2200.
21. Chow, J. C., D.W. Young, D. T. Golenbock, W. J. Christ, and F. Gusovsky. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274: 10689-10692.
22. Lehmann, A. K., A. Halstensen, S. Sornes, O. Rokke, and A. Waage. 1995. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect. Immun. 63: 2109-2112.
23. Hornef, M. W., M. J. Wick, M. Rhen, and S. Normark. 2002. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 3: 1033-1040.
24. van der Ley, P., and L. Steeghs. 2003. Lessons from an LPS-deficient Neisseria meningitidis mutant. J. Endotoxin Res. 9: 124-128.
25. Johansson, L., A. Rytkönen, P. Bergman, B. Albiger, H. Källström, T. Hökfelt, B. Agerberth, R. Cattaneo, and A.-B. Jonsson. 2003. CD46 in meningococcal disease. Science 301: 373-375.
26. Mrkic, B., J. Pavlovic, T. Rulicke, P. Volpe, C. J. Buchholz, D. Hourcade, J. P. Atkinson, A. Aguzzi, and R. Cattaneo. 1998. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72: 7420-7427.
27. Kemper, C., M. Leung, B. Stephensen, C. A. Pinkert, M. K. Liszewski, R. Cattaneo, and J. P. Atkinson. 2001. Membrane cofactor protein (MCP: CD46) expression in transgenic mice. Clin. Exp. Immunol. 124: 180-189.
28. Rahman, M., H. Källström, S. Normark, and A.-B. Jonsson. 1997. PilC of pathogenic Neisseria is associated with the bacterial cell surface. Mol. Microbiol. 25: 11-25.
29. Dyer, D. W., W. McKenna, J. P. Woods, and P. F. Sparling. 1987. Isolation by streptonigrin enrichment and characterization of a transferrin-specinc iron uptake mutant of Neisseria meningitidis. Microb. Pathog. 3: 351-363.
30. Albiger, B., L. Johansson, and A-B. Jonsson. 2003. Lipooligosaccharide- deficient Neisseria meningitidis shows altered pilus-associated characteristics. Infect. Immun. 71: 155-162.
31. Kellogg, D. S., Jr., I. R. Cohen, L. C. Norins, A. L. Schroeter, and G. Reising. Neisseria gonorrhoeae. 1968. II. Colonial variation and pathogenicity during 35 months in vitro. J. Bacteriol. 96: 595-605.
32. Brumowsky, P. R., T. J., Shi, H., Matsuda, J., Kopp, M. J. Villar, and T. Hokfelt. 2002. NPY Y1 receptors are present in axonal processes of DRG neurons. Exp. Neurol. 174: 1-10.
33. Coons, A. H. 1958. Fluorescent antibody methods. In General Cytochemical Methods. J. F. Danielli, ed. Academic Press, New York, p. 399-422.
34. Adams, J. C. 1992. Biotin amplification of biotin and horseradish peroxidase signals in histochemical strains. J. Histochem. Cytochem. 40: 1457-1463.
35. van Deuren, M., M. G. Netea, A. Hijmans, P. N. Demacker, C. Neeleman. R. W. Sauerwein, A. K. Bartelink, and J. W. van der Meer. 1998. Postttanscriptional down-regulation of tumor necrosis factors and interleukin-1β production in acute meningococcal infections. J. Infect. Dis. 177: 1401-1405.
36. Hackett, S. J., A. P. Thomson, and C. A. Hart. 2001. Cytokines, chemokines and other effector molecules involved in meningococcal disease. J. Med. Microbiol. 50: 847-859.
37. Bean, A. G., R. A. Freiberg, S. Andrade, S. Menon, and A. Zlotnik. 1993. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61: 4937-4939.
38. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177: 547-550.
39. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177: 1205-1208.
40. Nakae, H., S. Endo, K. Inada, T. Takakuwa, T. Kasai, and M. Yoshida. 1994. Serum complement levels and severity of sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84: 189-195.
41. Kielian, T. 2004. Microglia and chemokines in infectious diseases of the nervous system: views and reviews. Front. Biosci. 9: 732-750.
42. Imai, Y., I. Ibata, D. Ito, K. Ohsawa, and S. Kohsaka. 1996. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 224: 855-862.
43. Ito, D., Y. Imai, K. Ohsawa, K. Nakajima, Y. Fukuuchi, and S. Kohsaka. 1998. Microglia-specific localisation of a novel calcium binding protein, Iba1. Mol. Brain Res. 57: 1-9.
44. Warner, T. D., and J. A. Mitchell. 2004. Cyclooxygenases: new forms, new inhibitors, and lessons from me clinic. FASEB J. 18: 790-804.
45. Ball, H. J., H. G. MacDougall, I. S. McGregor, and N. H. Hunt. 2004. Cyclooxygenase-2 in the pathogenesis of murine cerebral, malaria. J. Infect. Dis. 189: 751-758.
46. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
47. Svanborg, C., G. Godaly, and M. Hedlund. 1999. Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr. Opin. Microbiol. 2: 99-105.
48. Zughaier, S. M., Y. L. Tzeng, S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens. 2004. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect. Immun. 72: 371-380.
49. Laflamme, N., S. Lacroix, and S. Rivest. 1999. An essential role of interleukin-1β in mediating NF-κB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J. Neurosci. 19: 10923-10930.
50. Yamagata, K., K. I. Andreasson, W. E. Kaufmann, C. A. Barnes, and P. F. Worley. 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neurons 11: 371-386.
51. Cao, C., K. Matsumura, K. Yamagata, and Y. Watanabe. 1995. Induction by lipopoly-saccharide of cyclooxygenase-2 mRNA in rat brain: its possible role in the febrile response. Brain Res. 697: 187-196.
52. de Vries, E. F., A. van Waarde, A. R. Buursma, and W. Vaalburg. 2003. Synthesis and in vivo evaluation of 18F-desbromo-DuP-697 as a PET tracer for cyclooxygenase-2 expression. J. Nucl. Med. 44: 1700-1706.
53. Nakajima, K., and S. Kohsaka. 1993. Functional roles of microglia in the brain. Neurosci. Res. 17: 187-203.
54. Kreutzberg, G. W. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19: 312-318.
55. Miyazaki, S., F. Ishikawa, T. Fujikawa, S. Nagata, and K. Yamaguchi. 2004. Intraperitoneal injection of lipopolysaccharide induces dynamic migration of gr-1high polymorphonuclear neutrophils in the murine abdominal cavity. Clin. Diagn. Lab. Immunol. 11: 452-457.
56. Sprong, T., N. Stikkelbroeck, P. van der Ley, L. Steeghs, L. van Alphen, N. Klein, MG. Netea, J. W. van der Meer, and M. van Deuren. 2001. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J. Leukocyte Biol. 70: 283-288.